Cutting edge: c-Kit signaling differentially regulates type 2 innate lymphoid cell accumulation and susceptibility to central nervous system demyelination in male and female SJL mice

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 5609-5613

  Russi, Abigail E ^a   Walker Caulfield, Margaret E ^b   Ebel, Mark E ^a   Brown, Melissa A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR; AUTACOID; CYTOKINE; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; LYMPHOID CELL; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TH17 CELL; TH2 CELL; TYPE 2 INNATE LYMPHOID CELL; ANIMAL; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE MODEL; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOCYTE COUNT; MAST CELL; METABOLISM; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; CYTOKINES; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNITY, INNATE; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MAST CELLS; MICE; MICE, TRANSGENIC; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; SEX FACTORS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84931479467     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500068     Document Type: Article

References (25)

1. Bove, R., and T. Chitnis. 2013. Sexual disparities in the incidence and course of MS. Clin. Immunol. 149: 201-210.
2. Khalid, R. 2014. Contributing factors in multiple sclerosis and the female sex bias. Immunol. Lett. 162(1 Pt A): 223-232.
3. Papenfuss, T. L., C. J. Rogers, I. Gienapp, M. Yurrita, M. McClain, N. Damico, J. Valo, F. Song, and C. C. Whitacre. 2004. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J. Neuroimmunol. 150: 59-69.
4. d mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol. 127: 191-198.
5. Secor, V. H., W. E. Secor, C. A. Gutekunst, and M. A. Brown. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191: 813-822.
6. Sayed, B. A., M. E. Walker, and M. A. Brown. 2011. Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. J. Immunol. 186: 3294-3298.
7. Christy, A. L., M. E. Walker, M. J. Hessner, and M. A. Brown. 2013. Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J. Autoimmun. 42: 50-61.
8. Sayed, B. A., A. L. Christy, M. E. Walker, and M. A. Brown. 2010. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J. Immunol. 184: 6891-6900.
9. Walker-Caulfield, M. E., J. K. Hatfield, and M. A. Brown. 2015. Dynamic changes in meningeal inflammation correspond to clinical exacerbations in a murine model of relapsing-remitting multiple sclerosis. J. Neuroimmunol. 278: 112-122.
10. Wong, L. Y., J. K. Hatfield, and M. A. Brown. 2013. Ikaros sets the potential for Th17 lineage gene expression through effects on chromatin state in early T cell development. J. Biol. Chem. 288: 35170-35179.
11. Bebo, B. F., Jr., E. Zelinka-Vincent, G. Adamus, D. Amundson, A. A. Vandenbark, and H. Offner. 1998. Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 84: 122-130.
12. Rostami, A., and B. Ciric. 2013. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J. Neurol. Sci. 333: 76-87.
13. Massa, S., G. Balciunaite, R. Ceredig, and A. G. Rolink. 2006. Critical role for c-kit (CD117) in T cell lineage commitment and early thymocyte development in vitro. Eur. J. Immunol. 36: 526-532.
14. Spits, H., D. Artis, M. Colonna, A. Diefenbach, J. P. Di Santo, G. Eberl, S. Koyasu, R. M. Locksley, A. N. McKenzie, R. E. Mebius, et al. 2013. Innate lymphoid cells - a proposal for uniform nomenclature. Nat. Rev. Immunol. 13: 145-149.
15. H2-inducing allergen exposures. J. Allergy Clin. Immunol. 133: 1142-1148.
16. + T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41: 283-295.
17. Saenz, S. A., M. C. Siracusa, L. A. Monticelli, C. G. Ziegler, B. S. Kim, J. R. Brestoff, L. W. Peterson, E. J. Wherry, A. W. Goldrath, A. Bhandoola, and D. Artis. 2013. IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells. J. Exp. Med. 210: 1823-1837.
18. Halim, T. Y., and A. N. McKenzie. 2013. New kids on the block: group 2 innate lymphoid cells and type 2 inflammation in the lung. Chest 144: 1681-1686.
19. Wong, S. H., J. A. Walker, H. E. Jolin, L. F. Drynan, E. Hams, A. Camelo, J. L. Barlow, D. R. Neill, V. Panova, U. Koch, et al. 2012. Transcription factor RORα is critical for nuocyte development. Nat. Immunol. 13: 229-236.
20. Klose, C. S., M. Flach, L. Möhle, L. Rogell, T. Hoyler, K. Ebert, C. Fabiunke, D. Pfeifer, V. Sexl, D. Fonseca-Pereira, et al. 2014. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157: 340-356.
21. Milovanovic, M., V. Volarevic, B. Ljujic, G. Radosavljevic, I. Jovanovic, N. Arsenijevic, and M. L. Lukic. 2012. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype. PLoS ONE 7: e45225.
22. Milovanovic, M., V. Volarevic, G. Radosavljevic, I. Jovanovic, N. Pejnovic, N. Arsenijevic, and M. L. Lukic. 2012. IL-33/ST2 axis in inflammation and immunopathology. Immunol. Res. 52: 89-99.
23. Jiang, H. R., M. Milovanović, D. Allan, W. Niedbala, A. G. Besnard, S. Y. Fukada, J. C. Alves-Filho, D. Togbe, C. S. Goodyear, C. Linington, et al. 2012. IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur. J. Immunol. 42: 1804-1814.
24. Li, M., Y. Li, X. Liu, X. Gao, and Y. Wang. 2012. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. J. Neuroimmunol. 247: 25-31.
25. + group 2 innate lymphoid cells are present in cord blood and in higher proportions in male than in female neonates. J. Allergy Clin. Immunol. 134: 228-230.